|
|||||
|
|||||
|
|
|
|
|
|
|
|||||
 |
 |
    |
|
|
|||
 |
|
||
|
|||
|
|
|
|
||||||||
|
Delaware House Committee Passes Resolution Opposing Army VX Disposal Plan
A Delaware House of Representatives committee yesterday voted unanimously to release a resolution for consideration by the full House opposing a U.S. Army plan for treatment and disposal of VX nerve agent (see GSN, April 1). Members of the Business, Corporations and Commerce Committee urged the Army to treat the nerve agent and its wastewater byproduct at the Indiana depot where the VX is stored, instead of shipping the byproduct to a Dupont facility in New Jersey for treatment and disposal in the Delaware River. “Is it not possible to handle this where it currently exists?” asked Representative Stephanie Ulbrich (R-Newark). The resolution has already been passed by the Delaware Senate. Members of the New Jersey and Delaware U.S. congressional delegations requested a formal review of the Army’s plan by the Centers for Disease Control and Prevention’s National Center for Environmental Health. Col. Jesse Barber of the Army Chemical Materials Agency said yesterday he expected to receive the results of that review within 60 to 90 days. “Should the CDC raise major issues, I would not proceed forward,” Barber said (Randall Chase, Associated Press/New York Newsday, April 8).
| ||||||||||
Back to top
